Severe anemia in a patient with multiple sclerosis treated with natalizumab
- PMID: 25713115
- DOI: 10.1212/01.wnl.0000461938.49936.52
Severe anemia in a patient with multiple sclerosis treated with natalizumab
Comment on
-
Severe anemia in a patient with multiple sclerosis treated with natalizumab.Neurology. 2014 Jul 22;83(4):374-5. doi: 10.1212/WNL.0000000000000614. Epub 2014 Jun 18. Neurology. 2014. PMID: 24944259 No abstract available.
Similar articles
-
Severe anemia in a patient with multiple sclerosis treated with natalizumab.Neurology. 2014 Jul 22;83(4):374-5. doi: 10.1212/WNL.0000000000000614. Epub 2014 Jun 18. Neurology. 2014. PMID: 24944259 No abstract available.
-
Comment on 'Fingolimod to treat severe MS after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?' Maillart et al.Mult Scler. 2014 Apr;20(4):510-1. doi: 10.1177/1352458513517281. Epub 2014 Jan 27. Mult Scler. 2014. PMID: 24468818 No abstract available.
-
Severe haematological complications during treatment with natalizumab.Mult Scler. 2012 Nov;18(11):1644-6. doi: 10.1177/1352458512442262. Epub 2012 Mar 21. Mult Scler. 2012. PMID: 22438058
-
Natalizumab for relapsing-remitting multiple sclerosis.Neurologia. 2011 Jul-Aug;26(6):357-68. doi: 10.1016/j.nrl.2010.10.004. Epub 2010 Dec 28. Neurologia. 2011. PMID: 21193250 Review. English, Spanish.
-
Natalizumab: state of the art and open questions.Neurol Sci. 2011 Jan;31 Suppl 3:313-5. doi: 10.1007/s10072-010-0430-2. Neurol Sci. 2011. PMID: 21107875 Review. No abstract available.
Cited by
-
Long-lasting severe anemia following treatment with natalizumab for relapsing-remitting multiple sclerosis: a case report.J Med Case Rep. 2024 May 13;18(1):245. doi: 10.1186/s13256-024-04562-8. J Med Case Rep. 2024. PMID: 38736000 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical